RNU7-65P

Across TCGA pan-cancer cohorts, RNU7-65P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-65P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-65P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-65P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, TGCT, and UCEC are the cancer types where RNU7-65P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.155	0.627	<.001	54	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
UCEC	OS	Tertile	All	0.703	0.928	.010	18	view →
ESCA	OS	Tertile	III,IV	0.802	0.368	.039	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-65P–BLCA (DFS)

Open the BLCA breakdown →